Patents by Inventor Damien GULLIVER

Damien GULLIVER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolite inspired selective oxytocin receptor agonists
    Patent number: 11414459
    Abstract: The present disclosure relates to compounds of Formula I being cyclic metabolites of oxytocin. These derivatives have enhanced selectivity for the oxytocin receptor.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: August 16, 2022
    Assignee: Kinoxis Therapeutics Pty Ltd
    Inventors: Michael Kassiou, Damien Gulliver, Tristan Reekie, Timothy Katte, William Jorgensen, Eryn Werry
  • METABOLITE INSPIRED SELECTIVE OXYTOCIN RECEPTOR AGONISTS
    Publication number: 20200255475
    Abstract: Compound of Formula I being cyclic metabolites of oxytocin. These derivatives have enhanced selectivity for the oxytocin receptor.
    Type: Application
    Filed: September 27, 2018
    Publication date: August 13, 2020
    Inventors: Michael KASSIOU, Damien GULLIVER, Tristan REEKIE, Timothy KATTE, William JORGENSEN, Eryn Werry